Zobrazeno 1 - 10
of 61
pro vyhledávání: '"A.-M. Duliege"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N. Cooper, J. Bussel, D. Arnold, A.-M. Duliege, R. Boccia, H. Zayed, M. Boxer, S. Tong, M. Scholzberg, R. Numerof, D. Liles, Q. Hill
Publikováno v:
HemaSphere. 3:306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ecda817ae404cf998af919d8c2fbf67
https://doi.org/10.1097/01.hs9.0000561096.37776.87
https://doi.org/10.1097/01.hs9.0000561096.37776.87
Autor:
E J, McFarland, W, Borkowsky, T, Fenton, D, Wara, J, McNamara, P, Samson, M, Kang, L, Mofenson, C, Cunningham, A M, Duliege, F, Sinangil, S A, Spector, E, Jimenez, Y, Bryson, S, Burchett, L M, Frenkel, R, Yogev, F, Gigliotti, K, Luzuriaga, R A, Livingston
Publikováno v:
The Journal of infectious diseases. 184(10)
Infants born to human immunodeficiency virus type 1 (HIV-1)-infected mothers were immunized at birth and at ages 4, 12, and 20 weeks with low-, medium-, or high-dose recombinant gp120 vaccine with MF59 adjuvant (HIV-1 SF-2 ; n = 52) or with MF59 alon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb85ffd218d10069b22663dd82375a7
https://pubmed.ncbi.nlm.nih.gov/11679925
https://pubmed.ncbi.nlm.nih.gov/11679925
Autor:
M J, McElrath, L, Corey, D, Montefiori, M, Wolff, D, Schwartz, M, Keefer, R, Belshe, B S, Graham, T, Matthews, P, Wright, G, Gorse, R, Dolin, P, Berman, D, Francis, A M, Duliege, D, Bolognesi, D, Stablein, N, Ketter, P, Fast
Publikováno v:
AIDS research and human retroviruses. 16(9)
Several immunogens induce HIV-specific neutralization and in vitro lymphoproliferation in adults at low HIV-1 risk, but responses in persons at high HIV-1 risk are not known. We performed a multicenter, double-blinded, adjuvant-controlled trial with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4b4abb6d58a14408f292e71b7e26d43
https://pubmed.ncbi.nlm.nih.gov/10875616
https://pubmed.ncbi.nlm.nih.gov/10875616
Autor:
M. Valentine, W. T. Shearer, J. Lambert, P. LaRussa, A. J. Melvin, Ross E. McKinney, M. Davi, Lynne M. Mofenson, K. Luzuriaga, Coleen K. Cunningham, K. A. Contello, M. Mirochnick, N. Deygoo, S. Laverty, K. M. Mohan, E. McBride, Minhee Kang, J. Pitt, L. Frenkel, Steven A Spector, M. Silio, Elizabeth J. McFarland, D. F. Cloutier, M. Lugo, M. Rivera, Diane W. Wara, T. Fenton, W. M. Dankner, B. Murante, S. Nachman, C. R. Salbenblatt, Marilyn Doyle, C. Vincent, William Borkowsky, D. Francis, T. Hastings, Alex Dorenbaum, M. J. Levin, N. Hutton, K. Mooney, R. Galvin, J L Sullivan, A. M. Duliege, E. Hawkins, Ellen G. Chadwick, J. McNamara
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 32(5)
To determine the safety of 2 candidate vaccines against human immunodeficiency virus type 1 (HIV-1), a randomized, placebo-controlled, multicenter trial compared low, medium, and high doses of the vaccines or an adjuvant among infants born to HIV-inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8873bba7ddcad8b3a303339bcb269215
https://pubmed.ncbi.nlm.nih.gov/11229849
https://pubmed.ncbi.nlm.nih.gov/11229849
Autor:
W, Borkowsky, D, Wara, T, Fenton, J, McNamara, M, Kang, L, Mofenson, E, McFarland, C, Cunningham, A M, Duliege, D, Francis, Y, Bryson, S, Burchett, S A, Spector, L M, Frenkel, S, Starr, R, Van Dyke, E, Jimenez
Publikováno v:
The Journal of infectious diseases. 181(3)
Children of mothers infected with human immunodeficiency virus type 1 (HIV-1) were immunized at birth and at 1, 3, and 5 months with 1 of 3 doses of recombinant gp120 vaccines prepared from SF-2 or MN strains of HIV-1. A total of 126 children were no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96dcc6db73fce8b426ab94e5c8ee9741
https://pubmed.ncbi.nlm.nih.gov/10720509
https://pubmed.ncbi.nlm.nih.gov/10720509
Autor:
B. Graham, R. El Habib, G. Gorse, Steffanie Sabbaj, Kent J. Weinhold, A. M. Duliege, Paul A. Goepfert, T. Evans, B. Savarese, M. L. Clements-Mann, Carol Smith, C. Harrow, M. Greenberg, Lawrence Corey, David A. Schwartz, David C. Montefiori, M. Klein, J. McElrath, Don Stablein, S. Frey, R. Dolin, J. L. Excler, M. Grabowsky, M. Keefer, P. Spearman, P. Wright, M. C. Walker, R. Belshe, M. Wolff, M. Mulligan
Publikováno v:
The Journal of infectious diseases. 183(4)
Elicitation of both memory cytotoxic T cell responses and human immunodeficiency virus (HIV)-neutralizing antibodies are desirable characteristics of an HIV vaccine regimen. We studied a combination vaccine regimen consisting of a canarypox (CP) vect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc1698ac17dbf19e7310c7fbc01bfd1
https://pubmed.ncbi.nlm.nih.gov/11170981
https://pubmed.ncbi.nlm.nih.gov/11170981
Autor:
S, Nitayaphan, C, Khamboonruang, N, Sirisophana, P, Morgan, J, Chiu, A M, Duliege, C, Chuenchitra, T, Supapongse, K, Rungruengthanakit, M, deSouza, J R, Mascola, K, Boggio, S, Ratto-Kim, L E, Markowitz, D, Birx, V, Suriyanon, J G, McNeil, A E, Brown, R A, Michael
Publikováno v:
Vaccine. 18(15)
Fifty-two human immunodeficiency virus type 1, seronegative Thai adults from the community were enrolled in a double-blind, placebo controlled, phase I/II trial of HIV SF2 gp120/MF59 vaccine to determine the safety and immunogenicity of this recombin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c25d54d8a3c4b57ae1435de185b0fa3a
https://pubmed.ncbi.nlm.nih.gov/10618542
https://pubmed.ncbi.nlm.nih.gov/10618542
Publikováno v:
HIV-Infekt ISBN: 9783642640827
The course of HIV infection is marked by a progressive decline in CD4+ T-lymphocytes (CD4+ cells) and increasing viral load as a consequence of unchecked viral replication [1–9]. As CD4+ cells die, the repertoire of responses to foreign pathogens g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4300fb6e3cf69fddcb1205957cd0ba68
https://doi.org/10.1007/978-3-642-59683-4_48
https://doi.org/10.1007/978-3-642-59683-4_48
Autor:
R B, Belshe, G J, Gorse, M J, Mulligan, T G, Evans, M C, Keefer, J L, Excler, A M, Duliege, J, Tartaglia, W I, Cox, J, McNamara, K L, Hwang, A, Bradney, D, Montefiori, K J, Weinhold
Publikováno v:
AIDS (London, England). 12(18)
To determine the ability of live attenuated canarypox virus expressing HIV antigens to induce CD8+ cytotoxic T-cell responses and to prime for neutralizing antibody responses to boosting with purified recombinant gp120 subunit vaccine.A prospective,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::780e26f43882210a3de2357fec527a54
https://pubmed.ncbi.nlm.nih.gov/9875578
https://pubmed.ncbi.nlm.nih.gov/9875578